BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18391996)

  • 21. Weblogs: a communication tool.
    Thielst CB
    J Healthc Manag; 2007; 52(5):287-9. PubMed ID: 17933184
    [No Abstract]   [Full Text] [Related]  

  • 22. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 23. Japan-China merger puts growth in East Asia first.
    Sipp D
    Nat Biotechnol; 2005 Aug; 23(8):907. PubMed ID: 16082348
    [No Abstract]   [Full Text] [Related]  

  • 24. This Dutchman is flying.
    Watson N
    Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
    [No Abstract]   [Full Text] [Related]  

  • 25. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 26. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry.
    Smaglik P; Frantz S
    Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255
    [No Abstract]   [Full Text] [Related]  

  • 27. Never again.
    Scott C
    Nat Biotechnol; 2010 Feb; 28(2):131. PubMed ID: 20139946
    [No Abstract]   [Full Text] [Related]  

  • 28. Experts predict bleak post-genomic era for drug R&D.
    Birmingham K
    Nat Med; 2001 Mar; 7(3):262. PubMed ID: 11231601
    [No Abstract]   [Full Text] [Related]  

  • 29. Achieving customer satisfaction through complaint or feedback.
    Driscoll C; Howard J
    Biomed Instrum Technol; 2010; 44(2):154-7. PubMed ID: 20586398
    [No Abstract]   [Full Text] [Related]  

  • 30. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 31. Transparent communication strategy on GMOs: will it change public opinion?
    Sinemus K; Egelhofer M
    Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK moves on Sirtris.
    Sipp D
    Nat Biotechnol; 2008 Jun; 26(6):595. PubMed ID: 18536662
    [No Abstract]   [Full Text] [Related]  

  • 33. Communication of gene technology--a difficult enterprise: a journalist's view on biotech communication.
    Spahl T; Deichmann T
    Biotechnol J; 2007 Sep; 2(9):1064-6. PubMed ID: 17768770
    [No Abstract]   [Full Text] [Related]  

  • 34. Exiting this year and into the next.
    Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
    [No Abstract]   [Full Text] [Related]  

  • 35. Paths to entrepreneurship in the life sciences.
    Mehta S
    Nat Biotechnol; 2004 Dec; 22(12):1609-12. PubMed ID: 15605429
    [No Abstract]   [Full Text] [Related]  

  • 36. Talking with the public--challenging the public scare.
    Sinemus K
    Biotechnol J; 2007 Sep; 2(9):1047. PubMed ID: 17768765
    [No Abstract]   [Full Text] [Related]  

  • 37. Ask the experts: how to get hired.
    Wong GH
    Nat Biotechnol; 2004 Nov; 22(11):1481-2. PubMed ID: 15529175
    [No Abstract]   [Full Text] [Related]  

  • 38. The science-business tango. Interview by Mari Paul.
    Hirth P
    Nat Biotechnol; 2006 Aug; 24(8):1035-6. PubMed ID: 16900153
    [No Abstract]   [Full Text] [Related]  

  • 39. Merv Turner.
    Turner M
    Nat Biotechnol; 2011 Mar; 29(3):186. PubMed ID: 21390005
    [No Abstract]   [Full Text] [Related]  

  • 40. Millennium ends Takeda's US shopping spree.
    Sipp D
    Nat Biotechnol; 2008 Jun; 26(6):593-5. PubMed ID: 18536661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.